The nation of Zimbabwe has rejected a major US healthcare agreement worth 367 million US dollars (272 million pounds) spanning five years because of the United States' request for confidential biological samples.
This rejection was revealed following a official document from December was leaked, which showed President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesman has since stated that the United States was seeking genetic material for research and commercial purposes but refused to guarantee the benefits from any future medical innovations.
"We are forced to start the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged further dialogue to find a agreement suitable to all parties so the country's vital HIV programme can continue.
Broader Implications
Zimbabwe's decision comes after a similar situation in neighbouring Kenya, where a court halted a similar health funding agreement after legal challenges were filed about the security of citizens' medical information.
After returning to office recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and accountability.
Based on reports, 16 nations in Africa have to date agreed to these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," he stated.
"In essence, our country would supply the raw materials for medical research without any certainty that the final treatments would be accessible to our people if a new disease outbreak emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining structures already established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This framework is designed to guarantee that when a country contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome continued dialogue with our American counterparts on how future collaboration might be designed in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but recommended that negotiations should continue given that a large portion of the country's Aids initiatives relied on external financing.
"Where technical issues arise, including those involving data governance or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," it said.
The halted deal underscores the complex tensions between accepting vital international aid and protecting national sovereignty in an ever more interconnected world.